FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912243308> ?p ?o ?g. }

• W2912243308 endingPage "1577" @default.
• W2912243308 startingPage "1568" @default.
• W2912243308 abstract "Background In the warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, variable phenotypic expression may delay diagnosis. Panleukopenia, malignancy, and chronic lung disease all affect morbidity and mortality risks. Routinely used treatments include immunoglobulins, granulocyte-colony stimulating factor (G-CSF), and antibiotics; recent trials with a target C-X-C chemokine receptor type 4 (CXCR4) antagonist show promising results. Objective We sought to characterize the largest cohort of patients with WHIM and evaluate their diagnostic and therapeutic management. Methods Data were collected from an international cohort of 18 patients with CXCR4 mutations. Results The clinical features manifested at 2.2 ± 2.6 years of age, whereas the disease diagnosis was delayed until 12.5 ± 10.4 years of age. Patients with WHIM commonly presented with a severe bacterial infection (78%). Pneumonia recurrence was observed in 61% of patients and was complicated with bronchiectasis in 27%. Skin warts were observed in 61% of patients at a mean age of 11 years, whereas human papilloma virus (HPV)-related malignancies manifested in 16% of patients. All the patients had severe neutropenia (195 ± 102 cells/mm3 at onset), whereas lymphopenia and hypogammaglobulinemia were detected in 88% and 58% of patients, respectively. Approximately 50% of patients received antibiotic prophylaxis, whereas G-CSF and immunoglobulin treatments were used in 72% and 55% of patients, respectively. Conclusions The WHIM syndrome onsets early in life and should be suspected in patients with chronic neutropenia. Patients with WHIM need careful monitoring and timely intervention for complications, mainly lung disease and HPV-related malignancies. We suggest that immunoglobulin therapy should be promptly considered to control the frequency of bacterial infections and prevent chronic lung damage. In the warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, variable phenotypic expression may delay diagnosis. Panleukopenia, malignancy, and chronic lung disease all affect morbidity and mortality risks. Routinely used treatments include immunoglobulins, granulocyte-colony stimulating factor (G-CSF), and antibiotics; recent trials with a target C-X-C chemokine receptor type 4 (CXCR4) antagonist show promising results. We sought to characterize the largest cohort of patients with WHIM and evaluate their diagnostic and therapeutic management. Data were collected from an international cohort of 18 patients with CXCR4 mutations. The clinical features manifested at 2.2 ± 2.6 years of age, whereas the disease diagnosis was delayed until 12.5 ± 10.4 years of age. Patients with WHIM commonly presented with a severe bacterial infection (78%). Pneumonia recurrence was observed in 61% of patients and was complicated with bronchiectasis in 27%. Skin warts were observed in 61% of patients at a mean age of 11 years, whereas human papilloma virus (HPV)-related malignancies manifested in 16% of patients. All the patients had severe neutropenia (195 ± 102 cells/mm3 at onset), whereas lymphopenia and hypogammaglobulinemia were detected in 88% and 58% of patients, respectively. Approximately 50% of patients received antibiotic prophylaxis, whereas G-CSF and immunoglobulin treatments were used in 72% and 55% of patients, respectively. The WHIM syndrome onsets early in life and should be suspected in patients with chronic neutropenia. Patients with WHIM need careful monitoring and timely intervention for complications, mainly lung disease and HPV-related malignancies. We suggest that immunoglobulin therapy should be promptly considered to control the frequency of bacterial infections and prevent chronic lung damage." @default.
• W2912243308 created "2019-02-21" @default.
• W2912243308 creator A5008408305 @default.
• W2912243308 creator A5017199970 @default.
• W2912243308 creator A5018481010 @default.
• W2912243308 creator A5021441291 @default.
• W2912243308 creator A5032466668 @default.
• W2912243308 creator A5037500529 @default.
• W2912243308 creator A5046431180 @default.
• W2912243308 creator A5047865328 @default.
• W2912243308 creator A5048891191 @default.
• W2912243308 creator A5050322107 @default.
• W2912243308 creator A5054791712 @default.
• W2912243308 creator A5060226601 @default.
• W2912243308 creator A5068327775 @default.
• W2912243308 creator A5069417543 @default.
• W2912243308 creator A5073010557 @default.
• W2912243308 creator A5084383371 @default.
• W2912243308 creator A5084435760 @default.
• W2912243308 creator A5090000319 @default.
• W2912243308 date "2019-05-01" @default.
• W2912243308 modified "2023-10-17" @default.
• W2912243308 title "Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies" @default.
• W2912243308 cites W1969733563 @default.
• W2912243308 cites W1980222090 @default.
• W2912243308 cites W1982198562 @default.
• W2912243308 cites W1983933064 @default.
• W2912243308 cites W1989981411 @default.
• W2912243308 cites W1995161495 @default.
• W2912243308 cites W1995178186 @default.
• W2912243308 cites W1995740020 @default.
• W2912243308 cites W2000557210 @default.
• W2912243308 cites W2002846504 @default.
• W2912243308 cites W2015959736 @default.
• W2912243308 cites W2022269773 @default.
• W2912243308 cites W2040742394 @default.
• W2912243308 cites W2051874580 @default.
• W2912243308 cites W2063556228 @default.
• W2912243308 cites W2077182047 @default.
• W2912243308 cites W2083348756 @default.
• W2912243308 cites W2083661379 @default.
• W2912243308 cites W2083774639 @default.
• W2912243308 cites W2086942621 @default.
• W2912243308 cites W2091390894 @default.
• W2912243308 cites W2093050626 @default.
• W2912243308 cites W2098551278 @default.
• W2912243308 cites W2102425902 @default.
• W2912243308 cites W2125385750 @default.
• W2912243308 cites W2143687530 @default.
• W2912243308 cites W2145087804 @default.
• W2912243308 cites W2162405272 @default.
• W2912243308 cites W2164170199 @default.
• W2912243308 cites W2167070743 @default.
• W2912243308 cites W2169101659 @default.
• W2912243308 cites W2284719294 @default.
• W2912243308 cites W2330866405 @default.
• W2912243308 cites W2619263060 @default.
• W2912243308 cites W2708440060 @default.
• W2912243308 cites W2741128687 @default.
• W2912243308 cites W2752463664 @default.
• W2912243308 cites W2765279402 @default.
• W2912243308 cites W4251962000 @default.
• W2912243308 doi "https://doi.org/10.1016/j.jaip.2019.01.045" @default.
• W2912243308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30716504" @default.
• W2912243308 hasPublicationYear "2019" @default.
• W2912243308 type Work @default.
• W2912243308 sameAs 2912243308 @default.
• W2912243308 citedByCount "33" @default.
• W2912243308 countsByYear W29122433082019 @default.
• W2912243308 countsByYear W29122433082020 @default.
• W2912243308 countsByYear W29122433082021 @default.
• W2912243308 countsByYear W29122433082022 @default.
• W2912243308 countsByYear W29122433082023 @default.
• W2912243308 crossrefType "journal-article" @default.
• W2912243308 hasAuthorship W2912243308A5008408305 @default.
• W2912243308 hasAuthorship W2912243308A5017199970 @default.
• W2912243308 hasAuthorship W2912243308A5018481010 @default.
• W2912243308 hasAuthorship W2912243308A5021441291 @default.
• W2912243308 hasAuthorship W2912243308A5032466668 @default.
• W2912243308 hasAuthorship W2912243308A5037500529 @default.
• W2912243308 hasAuthorship W2912243308A5046431180 @default.
• W2912243308 hasAuthorship W2912243308A5047865328 @default.
• W2912243308 hasAuthorship W2912243308A5048891191 @default.
• W2912243308 hasAuthorship W2912243308A5050322107 @default.
• W2912243308 hasAuthorship W2912243308A5054791712 @default.
• W2912243308 hasAuthorship W2912243308A5060226601 @default.
• W2912243308 hasAuthorship W2912243308A5068327775 @default.
• W2912243308 hasAuthorship W2912243308A5069417543 @default.
• W2912243308 hasAuthorship W2912243308A5073010557 @default.
• W2912243308 hasAuthorship W2912243308A5084383371 @default.
• W2912243308 hasAuthorship W2912243308A5084435760 @default.
• W2912243308 hasAuthorship W2912243308A5090000319 @default.
• W2912243308 hasBestOaLocation W29122433082 @default.
• W2912243308 hasConcept C126322002 @default.
• W2912243308 hasConcept C159654299 @default.
• W2912243308 hasConcept C203014093 @default.
• W2912243308 hasConcept C2776694085 @default.
• W2912243308 hasConcept C2777063308 @default.

• next